OpenAlex
PricingAboutJobs
Log inGet started
Work

P3.02c-101 Immunotherapy with Nivolumab in NSCLC Patients: One Centre Preliminary Results

HTML

Year: 2017
Type: article
Study design: Clinical Trial
Source: Journal of Thoracic Oncology
DOI: 10.1016/j.jtho.2016.11.1897
Authors: Sofia Lampaki, Efimia Boutsikou, Paul Zarogoulidis, Dionisios Spyratos, Ellada Eleptheriadou, Despoina Ioannidou, Christoforos Efthimiou, Theodoros Kontakiotis, Konstantinos Zarogoulidis
Institutions: Aristotle University of Thessaloniki, G. Papanikolaou General Hospital
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: nivolumab, non-small cell lung cancer, PD-1 inhibitors, immune checkpoint blockade, PD-L1 expression, platinum-refractory disease, second-line therapy, treatment efficacy, adverse events, squamous NSCLC, non-squamous non-small cell lung cancer
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W2568614195
FWCI: 0.121
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security